Almstead Neil Gregory 4

Accession 0001578850-25-000007

CIK 0001070081other

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 5:25 PM ET

Size

59.6 KB

Accession

0001578850-25-000007

Insider Transaction Report

Form 4

Period: 2025-11-25

PTC THERAPEUTICS, INC.PTCT

Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Transactions

Exercise/Conversion
Common Stock
2025-11-25$18.01/sh+2,475$44,575→ 103,100 total
Sale
Common Stock
2025-11-25$82.63/sh−911$75,276→ 102,189 total
Sale
Common Stock
2025-11-25$83.44/sh−990$82,606→ 101,199 total
Sale
Common Stock
2025-11-25$84.67/sh−574$48,601→ 100,625 total
Exercise/Conversion
Common Stock
2025-11-25$33.02/sh+2,020$66,700→ 102,645 total
Sale
Common Stock
2025-11-25$82.63/sh−689$56,932→ 101,956 total
Sale
Common Stock
2025-11-25$83.35/sh−862$71,848→ 101,094 total
Sale
Common Stock
2025-11-25$84.61/sh−289$24,452→ 100,805 total
Sale
Common Stock
2025-11-25$85.17/sh−180$15,331→ 100,625 total
Exercise/Conversion
Common Stock
2025-11-25$18.01/sh+8,410$151,464→ 109,035 total
Sale
Common Stock
2025-11-25$82.82/sh−2,790$231,068→ 106,245 total
Sale
Common Stock
2025-11-25$83.41/sh−3,663$305,531→ 102,582 total
Sale
Common Stock
2025-11-25$84.56/sh−1,757$148,572→ 100,825 total
Sale
Common Stock
2025-11-25$85.37/sh−200$17,074→ 100,625 total
Exercise/Conversion
Common Stock
2025-11-25$33.02/sh+47,624$1,572,544→ 148,249 total
Sale
Common Stock
2025-11-25$82.55/sh−13,514$1,115,581→ 134,735 total
Sale
Common Stock
2025-11-25$83.33/sh−21,844$1,820,261→ 112,891 total
Sale
Common Stock
2025-11-25$84.42/sh−9,171$774,216→ 103,720 total
Sale
Common Stock
2025-11-25$85.15/sh−3,095$263,539→ 100,625 total
Exercise/Conversion
Common Stock
2025-11-25$33.02/sh+11,399$376,395→ 112,024 total
Sale
Common Stock
2025-11-25$82.61/sh−3,744$309,292→ 108,280 total
Sale
Common Stock
2025-11-25$83.39/sh−4,834$403,107→ 103,446 total
Sale
Common Stock
2025-11-25$84.54/sh−2,621$221,579→ 100,825 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−2,475→ 8,410 total
Exercise: $18.01Exp: 2028-01-02→ Common Stock (2,475 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−2,020→ 47,624 total
Exercise: $33.02Exp: 2029-01-21→ Common Stock (2,020 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−8,410→ 0 total
Exercise: $18.01Exp: 2028-01-02→ Common Stock (8,410 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−47,624→ 0 total
Exercise: $33.02Exp: 2029-01-21→ Common Stock (47,624 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−11,399→ 0 total
Exercise: $33.02Exp: 2029-01-21→ Common Stock (11,399 underlying)

Holdings

Common Stock
(indirect: By Spouse)
6,179

Footnotes (21)

[F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024.
[F10]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F11]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.83 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F12]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.33 to $85.41 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F13]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $81.85 to $82.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F14]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.95 to $83.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F15]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.95 to $84.92 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F16]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.37 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F17]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F18]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F19]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F20]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.33 to $85.34 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F21]Currently exercisable.
[F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.96 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.96 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F7]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F8]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.16 to $85.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F9]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Documents

1 file

4
form4-11262025_051101.xmlPrimary

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

→

Entity typeother

Related Parties

filerCIK 0001578850

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 5:25 PM ET
Size: 59.6 KB

View on SEC.gov